JCV serology in time: 3 years of follow‐up
Sign Up to like & getrecommendations! Published in 2017 at "Acta Neurologica Scandinavica"
DOI: 10.1111/ane.12699
Abstract: Although many neurologists are reluctant to use natalizumab in MS (multiple sclerosis) given the increased risk for PML (progressive multifocal leukoencephalopathy), trust was regained with the introduction of JCV antibody titres as a potent disease‐modifying… read more here.
Keywords: serology time; serology; years follow; time years ... See more keywords